All News about Ionis Pharmaceuticals
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2024/06/24/Stocks-Photo-by-Jirapong-Manustrong-on-S.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/31/Medical-Examination-And-Healthcare-Busin.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
Exposures
Product Safety
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_0.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_3.png?width=1200&height=800&fit=crop)
The Latest Analyst Ratings For Ionis Pharmaceuticals
April 09, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/31/Biogen---logo.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/05/16/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://investorplace.com/wp-content/uploads/2020/07/pharma-stocks.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
Expert Outlook: Ionis Pharmaceuticals Through The Eyes Of 8 Analysts
January 18, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
![](https://cdn.benzinga.com/files/images/story/2024/Ozempic-weight-loss-pill_2.jpeg?width=1200&height=800&fit=crop)
![](https://www.marketbeat.com/logos/articles/med_20240308080734_are-these-5-undervalued-stocks-ready-to-break-out.jpg)
![](https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/AApharma-1.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2024/IONS.png?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/bff1e728-30ed-46c6-81e1-8bbc795929c0/small/01-primarylogo-color-bluex-100-jpg.jpg)
![](https://www.investors.com/wp-content/uploads/2024/01/A1-010824-biotech-Gash.jpg)
![](https://cdn.benzinga.com/files/images/story/2024/01/04/screenshot_2024-01-04_at_6.46.30_pm.png?width=1200&height=800&fit=crop)
2024 And Beyond – Exploring Six Investment Megatrends With Tema ETFs
January 04, 2024
Via Benzinga
Topics
ETFs
![](https://cdn.benzinga.com/files/images/story/2023/options_image_4.jpeg?width=1200&height=800&fit=crop)
10 Health Care Stocks Whale Activity In Today's Session
January 02, 2024
Via Benzinga
![](https://investorplace.com/wp-content/uploads/2023/05/trillion-dollar-companies1600-1024x576.png)
![](https://cdn.benzinga.com/files/images/story/2023/12/22/azn-ions_0.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/22/azn-ions.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/19/ions.png?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.